In the present study, we confirm findings from other studies in the general population and cohorts of COVID-19 patients which have shown that plasma ACE2 levels increase with age, are higher in men, and in patients with hypertension, congestive heart failure, diabetes, obesity and cancer9,17. Here, ACE2 is linked to obesity due to melanocortin 4 receptor deficiency.